- Home
- / Diaceutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Diaceutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
£1.2
2024-10-29
Market Capitalization
£103.5 M
2024-10-29
Revenue
£32.2 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 10.4M | 13.4M | 12.7M | 13.9M | 19.5M | 23.7M | 32.2M |
| Cost of goods sold | 3.5M | 2.8M | 2.4M | 1.6M | 2.5M | 3.7M | (826.0K) |
| Gross profit | 6.9M | 10.6M | 10.3M | 12.6M | 17.2M | 20.0M | 33.0M |
| Gross profit margin, % | 78.9% | 81.2% | 90.1% | 88.0% | 84.6% | 102.6% | |
| Operating expense total | 5.7M | 9.6M | 10.2M | 10.2M | 13.6M | 18.3M | 31.1M |
| Depreciation and amortization | 118.0K | 284.0K | 809.0K | 1.8M | 3.0M | 4.8M | 4.7M |
| EBITDA | 1.3M | 1.0M | 93.0K | 2.3M | 3.6M | 1.8M | 1.9M |
| EBITDA margin, % | 7.6% | 0.7% | 16.8% | 18.4% | 7.4% | 5.9% | |
| EBIT | 1.1M | 740.0K | (716.0K) | 550.0K | 575.0K | (3.0M) | (2.8M) |
| EBIT margin, % | 5.5% | -5.6% | 3.9% | 2.9% | -12.7% | -8.8% | |
| Interest income | 3.0K | 27.0K | 111.0K | 646.0K | 601.0K | ||
| Interest expense | 302.0K | 223.0K | 41.0K | 88.0K | 122.0K | 66.0K | 54.0K |
| Pre tax profit | 877.0K | 497.0K | (682.0K) | 462.0K | 564.0K | (2.4M) | (1.9M) |
| Income tax expense | 245.0K | 99.0K | (945.0K) | (99.0K) | (160.0K) | (692.0K) | (205.0K) |
| Net Income | 632.0K | 398.0K | 263.0K | 561.0K | 724.0K | (1.7M) | (1.7M) |